Ï㽶ÊÓƵ

Skip to main content
Casey J. Mehrhoff
No Rating Available
(Learn About Our Rating System)

Casey J. Mehrhoff, DO

Languages spoken: English, Spanish

Clinical Locations

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-587-4745

Ï㽶ÊÓƵ of Utah Hospital

Salt Lake City
801-662-4700
  • Dr. Casey Mehrhoff received her Master of Science in Biomedical Sciences and medical degree from Kansas City Ï㽶ÊÓƵ of Medicine, completed her Pediatric Residency at Loyola Ï㽶ÊÓƵ Medical Center in Chicago, and her Pediatric Hematology/Oncology Fellowship at Ann & Robert H. Lurie Children's Hospital of Chicago. She is currently an Assistant Professor of Pediatrics at the Ï㽶ÊÓƵ of Utah within the Division of Pediatric Hematology/Oncology at Primary Children's Hospital. Her clinical focus is on pediatric patients with solid tumor malignancies, with a specific focus on patients diagnosed with rare tumors and patients with cancer predisposition syndromes. She is the co-director and co-founder of the Pediatric Multidisciplinary Thyroid Team and is the co-director and founder of the Pediatric Multidisciplinary Melanoma program and is involved with these specialties on a national level. She is a provider in the high risk genetics cancer predisposition clinic at Huntsman Cancer Institute where she provides care and cancer screening for patients with certain cancer predisposition syndromes, such as Li Fraumeni Syndrome, DICER1, and Familial Adenomatous Polyposis, to name a few. Her research interest is in translational research and clinical trials.

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
  • Dr. Casey Mehrhoff received her Master of Science in Biomedical Sciences and medical degree from Kansas City Ï㽶ÊÓƵ of Medicine, completed her Pediatric Residency at Loyola Ï㽶ÊÓƵ Medical Center in Chicago, and her Pediatric Hematology/Oncology Fellowship at Ann & Robert H. Lurie Children's Hospital of Chicago. She is currently an Assistant Professor of Pediatrics at the Ï㽶ÊÓƵ of Utah within the Division of Pediatric Hematology/Oncology at Primary Children's Hospital. Her clinical focus is on pediatric patients with solid tumor malignancies, with a specific focus on patients diagnosed with rare tumors and patients with cancer predisposition syndromes. She is the co-director and co-founder of the Pediatric Multidisciplinary Thyroid Team and is the co-director and founder of the Pediatric Multidisciplinary Melanoma program and is involved with these specialties on a national level. She is a provider in the high risk genetics cancer predisposition clinic at Huntsman Cancer Institute where she provides care and cancer screening for patients with certain cancer predisposition syndromes, such as Li Fraumeni Syndrome, DICER1, and Familial Adenomatous Polyposis, to name a few. Her research interest is in translational research and clinical trials.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Hematology/Oncology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Fellowship Osteosarcoma - Ann & Robert H. Lurie Children’s Hospital Clinical Research Fellow
    Pediatric Hematology/Oncology - Northwestern Ï㽶ÊÓƵ Feinberg School of Medicine Fellow
    Residency Pediatrics - Loyola Ï㽶ÊÓƵ Medical Center Resident
    Osteopathic Medicine - Kansas City Ï㽶ÊÓƵ College of Osteopathic Medicine D.O.
    Graduate Training Biomedical Sciences - Kansas City Ï㽶ÊÓƵ M.S.
    Majors: Chemistry and Biology; Minors: Global Awareness and Business Development - Drury Ï㽶ÊÓƵ B.A.

    Selected Publications

    Journal Article

    1. Long CM, Mehrhoff C, Abdel-Latief E, Rech M, Laubham M (2018). Factors Influencing Pediatric Emergency Department Visits for Low-Acuity Conditions. Pediatr Emerg Care, 37(5), 265-268. ()
    2. Roy LN, Roy RN, Allen KA, Mehrhoff CJ, Henson IB, Stegner JM (2012). Buffer standards for the physiological pH of the zwitterionic compound of 3-(N-morpholino)propanesulfonic acid (MOPS) from T = (278.15 to 328.15) K. J Chem Thermodyn, 47, 21-27. ()

    Case Report

    1. Mehrhoff CJ, Hemenway CS, Suh E (2019). Emergence of a Ph-negative Clone in a Child With Ph+ ALL. J Pediatr Hematol Oncol, 42(6), e466-e468. ()